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basal cell carcinomaM. Lentini*, A. Simone, G. CarrozzaDepartment of Human Pathology–Odontostomatologic Pathology Unit,
Messina University, 98125 Messina, ItalyReceived 2 February 2004; accepted 10 February 2004Available onlineSummary Rare tumor of the oral cavity presenting as a gingival swelling without
bone involvement was present. The lesion, resected for mastication troubles,
histologically presented a basaloid cell proliferation predominantly organized in
nests formed by a peripheral palisading of cells with apically disposed nuclei.
Immunohistochemical stainings for the cytokeratin 19 and Ber-EP4 showed a marked
and diffuse positivity for the former, while the latter was negative. These results
support the diagnosis of peripheral ameloblastoma and allow us to distinguish it
from the basal cell carcinoma, which shares some histological features with this
unusual tumor of the oral cavity.c 2004 Elsevier Ltd. All rights reserved.
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Peripheral ameloblastoma is a rare tumour of
the oral soft tissue presenting the same pathologic
features of the osseous counterpart. 1 Because of
the location and its histopathologic features it is
possible to mistake it with basal cell carcinoma. 2
These two tumours present different biological
behaviour so the differential diagnosis is impor-
tant. 3 This could make necessary the use of cy-
tokeratin 19 and Ber-EP4, the first positive in
ameloblastic cells 4 and the second positive in the
neoplastic basal cells. 5 We describe a case of* Corresponding author. Tel.: +39 090 2212535.
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ential diagnosis with basal cell carcinoma and the
usefulness of the immumohistochemical staining
with cytokeratin 19 and Ber-EP4.Case report
Female, 69 years old, presented for 1 year on
the gingiva a firm submucosal nodular growth. The
lesion, 1.5 cm in the maximum diameter, brought
about trouble for the mastication. For this reason
she went to the surgeon to excise the lesion. A
radiographic examination excluded involvement of
the bone. The clinical diagnosis was “epulis”. Theved.
80 M. Lentini et al.surgical specimen was submitted for the histologi-
cal examination.
Macroscopically the specimen was a whitish,
firm, superficially ulcerated nodular lesion. The
sections obtained from the surgical specimen
showed microscopically a proliferation of basalioid
cells arranged in cords, islands and nests originat-
ing from the overlying gingival epithelium. The
neoplasm presented a peripheral palisading pat-
tern. The architecture was highly suggestive of
basal cell carcinoma, but some of the proliferative
nodules showed a central area of polyhedral cells,
sometimes splinded sometimes with squamous
metaplasia, reminiscent of the immature enamel
organ. The cells rimming the islands were cubic or
cylindric and had elongated, vescicular nuclei api-
cally polarized toward the central reticular areas.
Other areas showed small nests of immature cells
surrounded by abundant fibrous stroma. Immuno-
histochemical procedures showed diffuse positivity
of the neoplastic cells for CK19, in some areas
more marked in the palisading cells. Also positive
for the CK19 were some nests of epithelioid cells
scattered into the gingival epithelium. Ber-EP4 was
negative except some rare areas frankly basalioid
where the neoplastic cells were slightly positive.
EMA was focally positive in areas with squamoid
metaplasia, but otherwise it was negative. The
diagnosis of peripheral ameloblastoma was made.Discussion
Peripheral ameloblastoma is an unusual variant
of odontogenic tumor. 1 Extraosseous location is
the peculiar feature of this type of tumor, other-
wise similar to the classical ameloblastoma. It is
rare and its incidence is about 1% of all amelobl-
astomas. It is an indolent tumour, often presenting
as a nodular growth of the gingiva, and it is char-
acterized by a benign behaviour, cured by local
excision. 3 Histologically the major differential
diagnosis is the basal cell carcinoma of the skin
with which it shares some microscopical features,
so sometimes the differential diagnosis can be
difficult. 2 Like the basal cell carcinoma of the skin,
the peripheral ameloblastoma is characterized by a
proliferation of basal cells often arranged in nests
included in a fibrous stroma with areas of contact
with the epidermis. The arrangement of the rim
cells of the nests are the same, that is typically
palisading, but in contrast with the basal cell car-
cinoma, whose cells have the nuclei located on thebasis of the cytoplasm, the rim cells of the
peripheral ameloblastoma have the nuclei located
on the upper part of the cytoplasm. Furthermore
the immunohistochemical analysis outlines the
differences between these two types of tumors.
The basal cell carcinoma shows diffuse and
marked positivity for Ber-Ep4 5 and negativity for
cytokeratin 19; 6 on the contrary, the peripheral
ameloblastoma is always negative for Ber-EP4,
except very focal areas in which a true basalioid
differentiation is present, and diffusely and mark-
ely positive for the cytokeratin 19. 4 Very peculiar
is the presence in the gingival epithelium of some
clusters of cytokeratin 19 positive cells otherwise
negative. It could be that these cells represent
epithelial rests of the dental lamina in the gingival
epithelium.
Therefore the immunohistochemical stainings
are the clue for the differential diagnosis between
peripheral ameloblastoma and basal cell carcinoma
overall in the cases in which peculiar histological
features are not present or when an incisional
biopsy is made. Moreover it is important to differ-
entiate these two neoplasms because having dif-
ferent biological behaviour they need different
treatment. In fact while a simple local excision is
often resolutive for peripheral ameloblastoma
without risk of recurrence, the basal cell carci-
noma needs a larger excision to exclude the risk of
local recurrence and/or regional metastases 3. For
this reason we suggest the use of cytokeratin
19 and Ber-EP4 when a tumor of the soft part of
the oral cavity with histological features of basal
cell carcinoma and/or peripheral ameloblastoma
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